NASDAQ:AARD | Cash Flow Statement | Aardvark Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$14.39M
2026-03-31-$21.59M$11,000.00-$18.87M$34.25M$4,000.00
2025-12-31-$17.6M$10,000.00-$16.81M$0.00$24.3M$274,000.00
2025-09-30-$16.32M
2025-06-30-$14.37M
2025-03-31-$9.31M$5,000.00-$11.39M$0.00-$112.62M$88.88M
2024-12-31-$8.78M$8,000.00-$7.73M$6,000.00-$11.9M-$1.01M
2024-09-30-$4.18M
2024-06-30-$5.45M
2024-03-31-$2.18M$2,000.00-$2.19M$5,000.00-$5,000.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$57.59M$36,000.00-$54.17M$95,000.00-$49.67M$89.25M
2024-12-31-$20.59M$16,000.00-$18.09M$109,000.00-$12M$81.99M